Associate Professor Angela Webster

Associate Professor
Public Health, School of Public Health

Telephone +61 2 9036 9125
Fax +61 2 9351 5049

Map

Biographical details

Angela is a Nephrologist and Transplant Physician, having trained in England, Scotland and Australia. She studied Clinical Epidemiology at the University of Sydney, and was awarded a PhD for her thesis Immunosuppression and malignancy in End Stage Kidney Disease in 2006. She now splits her time working as a Staff Specialist in Renal Medicine and Transplantation at Westmead Hospital and as an Associate Professor in Clinical Epidemiology in the Sydney School of Public Health. She is the Executive Officer of the National Islet and Pancreas Transplant Registry, a member of the Australia and New Zealand Dialysis and Transplant registry (ANZDATA) Cancer working group and of the New South Wales Transplant Advisory Committee. She is Chair-elect of the Scientific Program and Education Committee (SPEC) of the Australian and New Zealand Society of Nephrology, and is deputy coordinating editor of the Cochrane Renal Group, part of the Cochrane Collaboration

Research interests

Angela's areas of research interest include the critical exploration of randomized trial methodology, the evaluation of diagnostic tests in clinical practice, the application of advanced statistical concepts in meta-analysis, the manipulation and analysis of large datasets, the methods and application of linkage of large national databases, and design and interpretation of cohort studies.

Her research themes include the interaction of chronic diseases, specifically chronic kidney disease, with cancer and with cardiovascular disease including stroke. She has an interest in the cognitive effects of chronic diseases, and the impact this has on health. She is interested in ways to promote self-management to help people live well with chronic disease

Teaching and supervision

Angela is part of the clinical epidemiology team, which offers the following degrees: Master of Medicine (Clinical Epidemiology), Master of Science in Medicine (Clinical Epidemiology), Graduate Diploma of Medicine (Clinical Epidemiology), and Graduate Certificate of Medicine (Clinical Epidemiology)

Angela coordinates several units in the Clinical Epidemiology degree program, including literature searching (CEPI5102), advanced systematic reviews (CEPI5204) and doing a systematic review (CEPI5204) and writing and reviewing medical papers (CEPI5214). She also contributes to evidence based medicine teaching and the population health components of the Graduate Medical Program

Current projects

1. Melanoma after transplantation

2. Cognition and Health Literacy in chronic kidney disease

3. Management of type 1 diabetes and end stage kidney disease in Australia

4. Cancer and survival after end stage kidney disease

5. Stroke and chronic kidney disease

6. Strategies to improve patient self management in chronic disease

7. Monitoring strategies for cardiovascular risk in chronic kidney disease

8. Biovigilance in transplantation

International links

Belgium

(European Renal Association) Angela provides training to ERA methods support team fellows, and collaborates on European Renal Best Practice Guidelines (see www.european-renal-best-practice.org/)

Global

(Cochrane Collaboration) Angela is the deputy co-ordinating editor of the Cochrane Renal Group, a review group of the Cochrane Collabroation (www.cochrane-renal.org/ and www.cochrane.org/)

United States

(Kidney Disease Improving Global Outcomes ) Angela is a member of the KDIGO methods committee, working on recommendations for international clinical practice guideline renewal

Selected grants

2015

  • Evidence and outcomes: biovigilance and surveillance in transplantation; Webster A; DVC Research/Brown Fellowships.

2011

  • Improving the evidence base for diagnostic decision making in chronic kidney disease; Webster A; Royal Australasian College of Physicians/Research Support.

2010

  • Improving the evidence base for diagnostic decision making in chronic kidney disease; Webster A; Royal Australasian College of Physicians/Jacquot Research Establishment Award.

Selected publications

Download citations: PDF RTF Endnote

Book Chapters

  • Buell, J., Shores, N., Gross, T., Chapman, J., Webster, A. (2014). Post-Transplant Lymphoproliferative Disorder. In James Neuberger, James Ferguson and Philip N. Newsome (Eds.), Liver Transplantation: Clinical Assessment and Management, (pp. 325-336). Oxford: John Wiley & Sons.
  • Webster, A., Wong, G., McDonald, S. (2011). Cancer Report. In Stephen McDonald & Kylie Hurst (Eds.), ANZDATA Registry 2011 Report, (pp. 10-1-10-11). Australia: ANZDATA Registry Australia.
  • Webster, A., Wong, G., McDonald, S. (2010). Cancer Report. In S. McDonald, L. Excell, B. Livingstone (Eds.), ANZDATA Registry Report 2010, (pp. 1-11). Australia: ANZDATA Registry Australia.
  • Matheson, S., Masson, P., Webster, A., Craig, J. (2010). Prophylaxis and Treatment of Urinary Tract Infections in Adults. In Philipp Dahm and Roger Dmochowski (Eds.), Evidence-Based Urology, (pp. 72-93). United Kingdom: Wiley-Blackwell Publishing.
  • Murali, K., Webster, A. (2008). Post Transplant Malignancy. In David Harris (Eds.), Clinical Cases in Kidney Disease, (pp. 355-372). Australia: McGraw Hill.
  • Murali, K., Webster, A. (2007). Post-transplant malignancy. In David Harris (Eds.), Clinical Cases in Kidney Disease, (pp. 426-444). Australia: McGraw Hill.

Journals

  • Lim, W., Turner, R., Chapman, J., Ma, M., Webster, A., Craig, J., Wong, G. (2014). Acute Rejection, T-Cell-Depleting Antibodies, and Cancer After Transplantation. Transplantation, 97(8), 817-925. [More Information]
  • Nagler, E., Webster, A., Bolignano, D., Haller, M., Nistor, I., van der Veer, S., Fouque, D., Van Biesen, W. (2014). European Renal Best Practice (ERBP) Guideline development methodology: towards the best possible guidelines. Nephrology, Dialysis, Transplantation, 29(4), 731-738. [More Information]
  • Neuen, B., Gunnarsson, R., Webster, A., Baer, R., Golledge, J., Mantha, M. (2014). Predictors of Patency after Balloon Angioplasty in Hemodialysis Fistulas: A Systematic Review. Journal of Vascular and Interventional Radiology, 25(6), 917-924. [More Information]
  • Iff, S., Wong, G., Webster, A., Flood, V., Wang, J., Mitchell, P., Craig, J. (2014). Relative Energy Balance, CKD, and Risk of Cardiovascular and All-Cause Mortality. American Journal of Kidney Diseases, 63(3), 437-445. [More Information]
  • Vajdic, C., Chong, A., Kelly, P., Meagher, N., van Leeuwen, M., Grulich, A., Webster, A. (2014). Survival After Cutaneous Melanoma in Kidney Transplant Recipients: A Population-Based Matched Cohort Study. American Journal of Transplantation, 14(6), 1368-1375. [More Information]
  • Myint, T., Rangan, G., Webster, A. (2014). Treatments to slow progression of autosomal dominant polycystic kidney disease: systematic review and meta -analysis of randomized trials. Nephrology, 19(4), 217-226. [More Information]
  • Palmer, S., Di Micco, L., Razavian, M., Craig, J., Perkovic, V., Pellegrini, F., Jardine, M., Webster, A., Zoungas, S., Strippoli, G., et al (2013). Antiplatelet agents for chronic kidney disease. Cochrane Database of Systematic Reviews, 2013 (4), 1-136. [More Information]
  • Palmer, S., Di Micco, L., Razavian, M., Craig, J., Ravani, P., Perkovic, V., Tognoni, G., Graziano, G., Jardine, M., Pellegrini, F., Webster, A., Strippoli, G., et al (2013). Antiplatelet Therapy to Prevent Hemodialysis Vascular Access Failure: Systematic Review and Meta-analysis. American Journal of Kidney Diseases, 61(1), 112-122. [More Information]
  • Hodson, E., Ladhani, M., Webster, A., Strippoli, G., Craig, J. (2013). Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients. Cochrane Database of Systematic Reviews, 2, 1-198. [More Information]
  • Chapman, J., Webster, A., Wong, G. (2013). Cancer in the Transplant Recipient. Cold Spring Harbor Perspectives in Medicine, 3(7), 1-15. [More Information]
  • Tait, B., Susal, C., Gebel, H., Nickerson, P., Zachary, A., Claas, F., Reed, E., Bray, R., Campbell, P., Chapman, J., Webster, A., et al (2013). Consensus Guidelines on the Testing and Clinical Management Issues Associated With HLA and Non-HLA Antibodies in Transplantation. Transplantation, 95(1), 19-47. [More Information]
  • Masson, P., Duthie, F., Ruster, L., Kelly, P., Merrifield, A., Craig, J., Webster, A. (2013). Consistency and Completeness of Reported Outcomes in Randomized Trials of Primary Immunosuppression in Kidney Transplantation. American Journal of Transplantation, 13(11), 2892-2901. [More Information]
  • Kim, S., Webster, A., Craig, J. (2013). Current trends in immunosuppression following organ transplantation in children. Current Opinion in Organ Transplantation, 18(5), 537-542. [More Information]
  • Henderson, L., Masson, P., Craig, J., Roberts, M., Flanc, R., Strippoli, G., Webster, A. (2013). Induction and Maintenance Treatment of Proliferative Lupus Nephritis: A Meta-analysis of Randomized Controlled Trials. American Journal of Kidney Diseases, 61(1), 74-87. [More Information]
  • Tsoi, D., Porwal, M., Webster, A. (2013). Interventions for smoking cessation and reduction in individuals with schizophrenia. Cochrane Database of Systematic Reviews, 2, 1-101. [More Information]
  • Li, L., McGee, R., Isbister, G., Webster, A. (2013). Interventions for the symptoms and signs resulting from jellyfish stings (Review). Cochrane Database of Systematic Reviews, 2013 (12), 1-42. [More Information]
  • Owers, D., Webster, A., Strippoli, G., Kable, K., Hodson, E. (2013). Pre-emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant recipients (Review). Cochrane Database of Systematic Reviews, 2013 (2), 1-81. [More Information]
  • McGee, R., Craig, J., Rogerson, T., Webster, A. (2013). Systematic reviews of surgical procedures in children: Quantity, coverage and quality. Journal of Paediatrics and Child Health, 49(4), 319-324. [More Information]
  • Myint, T., Turner, R., Craig, J., Cross, N., Kable, K., Nankivell, B., Chapman, J., Webster, A., O'Connell, P., Dwyer, D., Jeoffreys, N., Wong, G., et al (2013). Test performance characteristics of quantitative nucleic acid testing for polyomaviruses in kidney and kidney-pancreas transplant recipients. Clinical Transplantation, 27(5), 571-579. [More Information]
  • Rogerson, T., Chen, S., Kok, J., Hayen, A., Craig, J., Sud, K., Kable, K., Webster, A. (2013). Tests for Latent Tuberculosis in People With ESRD: A Systematic Review. American Journal of Kidney Diseases, 61(1), 33-43. [More Information]
  • Wong, G., Turner, R., Chapman, J., Howell, M., Lim, W., Webster, A., Craig, J. (2013). Time on Dialysis and Cancer Risk After Kidney Transplantation. Transplantation, 95(1), 114-121. [More Information]
  • Wyld, M., Morton, R., Hayen, A., Howard, K., Webster, A. (2012). A Systematic Review and Meta-Analysis of Utility-Based Quality of Life in Chronic Kidney Disease Treatments. PLoS Medicine, 9(9), 1-10. [More Information]
  • Nagler, E., Webster, A., Vanholder, R., Zoccali, C. (2012). Antidepressants for depression in stage 3-5 chronic kidney disease: a systematic review of pharmacokinetics, efficacy and safety with recommendations by European Renal Best Practice (ERBP). Nephrology, Dialysis, Transplantation, 27(10), 3736-3745. [More Information]
  • Jun, M., Venkataraman, V., Razavian, M., Cooper, B., Zoungas, S., Ninomiya, T., Webster, A., Perkovic, V. (2012). Antioxidants for chronic kidney disease (Review). Cochrane Database of Systematic Reviews, 10, 1-61. [More Information]
  • Webster, A., Wang, L. (2012). Cardiac testing for coronary artery disease in potential kidney transplant recipients. Nephrology, 17(5), 517-520. [More Information]
  • Wong, G., Howard, K., Chapman, J., Chadban, S., Cross, N., Tong, A., Webster, A., Craig, J. (2012). Comparative survival and economic benefits of deceased donor kidney transplantation and dialysis in people with varying ages and co-morbidities. PLoS One, 7(1), 1-9. [More Information]
  • Morton, R., Snelling, P., Webster, A., Rose, J., Masterson, R., Johnson, D., Howard, K. (2012). Dialysis Modality Preference of Patients With CKD and Family Caregivers: A Discrete-Choice Study. American Journal of Kidney Diseases, 60(1), 102-111. [More Information]
  • Palmer, S., Di Micco, L., Razavian, M., Craig, J., Perkovic, V., Pellegrini, F., Copetti, M., Graziano, G., Tognoni, G., Jardine, M., Webster, A., Strippoli, G., et al (2012). Effects of Antiplatelet Therapy on Mortality and Cardiovascular and Bleeding Outcomes in Persons With Chronic Kidney Disease: A Systematic Review and Meta-analysis. Annals of Internal Medicine, 156(6), 445-459. [More Information]
  • Morton, R., Snelling, P., Webster, A., Rose, J., Masterson, R., Johnson, D., Howard, K. (2012). Factors influencing patient choice of dialysis versus conservative care to treat end-stage kidney disease. CMAJ - Canadian Medical Association Journal, 184(5), E277-E283. [More Information]
  • Wong, G., Howard, K., Chapman, J., Pollock, C., Chadban, S., Salkeld, G., Tong, A., Williams, N., Webster, A., Craig, J. (2012). How do people with chronic kidney disease value cancer-related quality of life? Nephrology, 17(1), 32-41. [More Information]
  • Chadban, S., Barraclough, K., Campbell, S., Clark, C., Coates, P., Cohney, S., Cross, N., Eris, J., Henderson, L., Howell, M., O'Connell, P., Webster, A., Wong, G., et al (2012). KHA-CARI guideline: KHA-CARI Adaptation of the KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients. Nephrology, 17(3), 204-214. [More Information]
  • McGee, R., Webster, A., Rogerson, T., Craig, J. (2012). Medical device regulation in Australia: safe and effective? Medical Journal of Australia, 196(4), 256-260. [More Information]
  • Webster, A., Hodson, E. (2012). Parenteral versus oral iron therapy for adults and children with chronic kidney disease. Nephrology, 17(8), 774-775. [More Information]
  • Albaramki, J., Hodson, E., Craig, J., Webster, A. (2012). Parenteral versus oral iron therapy for adults and children with chronic kidney disease (Review). Cochrane Database of Systematic Reviews, 1, 1-97. [More Information]
  • Morton, R., Turner, R., Howard, K., Snelling, P., Webster, A. (2012). Patients Who Plan for Conservative Care Rather Than Dialysis: A National Observational Study in Australia. American Journal of Kidney Diseases, 59(3), 419-427. [More Information]
  • Webster, A., Mahady, S. (2012). The Importance of Quality Appraisal in Meta-analysis. Clinical Gastroenterology and Hepatology, 10(9), 1057-1057. [More Information]
  • Glotz, D., Chapman, J., Dharnidharka, V., Hanto, D., Castro, M., Hirschc, H., Leblond, V., Mehta, A., Moulin, B., Pagliuca, A., Webster, A., et al (2012). The Seville Expert Workshop for Progress in Posttransplant Lymphoproliferative Disorders. Transplantation, 94(8), 784-793. [More Information]
  • Henderson, L., Masson, P., Craig, J., Flanc, R., Roberts, M., Strippoli, G., Webster, A. (2012). Treatment for lupus nephritis (Review). Cochrane Database of Systematic Reviews, 12, 1-226. [More Information]
  • Wang, L., Fahim, M., Hayen, A., Mitchell, R., Baines, L., Lord, S., Craig, J., Webster, A. (2011). Cardiac testing for coronary artery disease in potential kidney transplant recipients. Cochrane Database of Systematic Reviews, 2011 (12), 1-104. [More Information]
  • Wang, L., Fahim, M., Hayen, A., Mitchell, R., Lord, S., Baines, L., Craig, J., Webster, A. (2011). Cardiac Testing for Coronary Artery Disease in Potential Kidney Transplant Recipients: A Systematic Review of Test Accuracy Studies. American Journal of Kidney Diseases, 57(3), 476-487. [More Information]
  • Morton, R., Tong, A., Webster, A., Snelling, P., Howard, K. (2011). Characteristics of dialysis important to patients and family caregivers: a mixed methods approach. Nephrology, Dialysis, Transplantation, 26(12), 4038-4046. [More Information]
  • McGee, R., Neuen, B., Mitchell, R., Craig, J., Webster, A. (2011). Diagnostic Test Studies in Nephrology: Quantity, Quality, and Scope. American Journal of Kidney Diseases, 58(6), 921-927. [More Information]
  • Komala, M., Pianta, T., Jardine, M., Webster, A., Perkovic, V. (2011). Interventions for preventing intradialytic hypotension inhaemodialysis patients (Protocol). Cochrane Database of Systematic Reviews, (12), 1-12. [More Information]
  • McGee, R., Bakens, A., Wiley, K., Riordan, S., Webster, A. (2011). Probiotics for patients with hepatic encephalopathy. Cochrane Database of Systematic Reviews, (11 article number CD008716), CD008716-1-CD008716-76. [More Information]
  • Wong, G., Howard, K., Webster, A., Chapman, J., Craig, J. (2011). Screening for renal cancer in recipients of kidney transplants. Nephrology, Dialysis, Transplantation, 26(5), 1729-1739. [More Information]
  • Wong, G., Howard, K., Chapman, J., Tong, A., Bourke, M., Hayen, A., Macaskill, P., Hope, R., Williams, N., Kieu, A., Allen, R., Chadban, S., Pollock, C., Webster, A., Craig, J., et al (2011). Test performance of faecal occult blood testing for the detection of bowel cancer in people with chronic kidney disease (DETECT) protocol. BMC Public Health, 11(June), 516-(7pp). [More Information]
  • Mahady, S., Webster, A., Walker, S., Sanyal, A., George, J. (2011). The role of thiazolidinediones in non-alcoholic steatohepatitis - A systematic review and meta analysis. Journal of Hepatology, 55(6), 1383-1390. [More Information]
  • McGee, R., Su, M., Kelly, P., Higgins, G., Craig, J., Webster, A. (2011). Trial Registration and Declaration of Registration by Authors of Randomized Controlled Trials. Transplantation, 92(10), 1094-1100. [More Information]
  • Razavian, M., Di Micco, L., Palmer, S., Craig, J., Perkovic, V., Zoungas, S., Webster, A., Jardine, M., Strippoli, G. (2010). Antiplatelet agents for chronic kidney disease. Cochrane Database of Systematic Reviews, 2010 (11), 1-16. [More Information]
  • Cross, N., Craig, J., Webster, A. (2010). Asking the right question and finding the right answers. Nephrology, 15(1), 8-11. [More Information]
  • van Leeuwen, M., Webster, A., McCredie, M., Stewart, J., McDonald, S., Amin, J., Kaldor, J., Chapman, J., Vajdic, C., Grulich, A. (2010). Effect of reduced immunosuppression after kidney transplant failure on risk of cancer: population based retrospective cohort study. BMJ, 340(c570), c570-1-c570-6. [More Information]
  • Tsoi, D., Porwal, M., Webster, A. (2010). Efficacy and safety of bupropion for smoking cessation and reduction in schizophrenia: a systematic review and meta-analysis. British Journal of Psychiatry, 196(5), 346-353. [More Information]
  • Craig, J., Webster, A., Loy, C. (2010). How long should treatments be continued? BMJ, 341, 409-414. [More Information]
  • Kelly, P., Webster, A., Craig, J. (2010). How many patients do we need for a clinical trial? Demystifying sample size calculations. Nephrology, 15, 725-731. [More Information]
  • Cullis, J., Webster, A. (2010). How to get the most from the medical literature: Keeping up to date in nephrology. Nephrology, 15(3), 269-276. [More Information]
  • Webster, A., Cross, N., Mitchell, R., Craig, J. (2010). How to get the most from the medical literature; searching the medical literature effectively. Nephrology, 15(1), 12-19. [More Information]
  • Jun, M., Zoungas, S., Perkovic, V., Webster, A. (2010). How to read a report of a randomized controlled trial. Nephrology, 15(2), 153-157. [More Information]
  • Henderson, L., Craig, J., Willis, N., Tovey, D., Webster, A. (2010). How to write a Cochrane systematic review. Nephrology, 15(6), 617-624. [More Information]
  • Webster, A., Ruster, L., McGee, R., Matheson, S., Higgins, G., Willis, N., Chapman, J., Craig, J. (2010). Interleukin 2 receptor antagonists for kidney transplant recipients. Cochrane Database of Systematic Reviews, CD003897(1), 1-146. [More Information]
  • Webster, A., Ruster, L., McGee, R., Matheson, S., Higgins, G., Willis, N., Chapman, J., Craig, J. (2010). Interleukin-2 Receptor Antagonists Versus ATG FOR Kidney Transplant Recipients; An Updated Cochrane Systematic Review. Transplantation, 90(Suppl: 22), 22.
  • Tsoi, D., Porwal, M., Webster, A. (2010). Interventions for smoking cessation and reduction in individuals with schizophrenia (Review). Cochrane Database of Systematic Reviews, 6(6), 1-75. [More Information]
  • McGee, R., Su, M., Kelly, P., Higgins, G., Craig, J., Webster, A. (2010). Is trial registration working in nephrology? Nephrology, 15(S4), 78-78. [More Information]
  • Wong, G., Howard, K., Chapman, J., Cross, N., Chadban, S., Webster, A., Craig, J. (2010). Life years gain and cost-savings on the kidney transplant waiting list. Transplantation, 90(Suppl 972), 972.
  • Gallagher, M., Kelly, P., Jardine, M., Perkovic, V., Cass, A., Craig, J., Eris, J., Webster, A. (2010). Long-Term Cancer Risk of Immunosuppressive Regimens after Kidney Transplantation. Journal of the American Society of Nephrology, 21(5), 852-858. [More Information]
  • Vajdic, C., van Leeuwen, M., Turner, J., McDonald, A., Webster, A., McDonald, S., Chapman, J., Kaldor, J., Grulich, A. (2010). No excess risk of follicular lymphoma in kidney transplant and HIV-related immune deficiency. International Journal of Cancer, 127, 2732-2735. [More Information]
  • Cross, N., Macaskill, P., Hayen, A., Webster, A., Wong, G., O'Connell, P., Chapman, J., Nankivell, B., Craig, J. (2010). Optimizing Serum Creatinine Monitoring For The Rapid Detection Of Complications In The Early Post-Kidney Transplant Period. Transplantation, 90(Suppl 2:977), 977.
  • Morton, R., Howard, K., Webster, A., Snelling, P. (2010). Patient INformation about Options for Treatment (PINOT): a prospective national study of information given to incident CKD Stage 5 patients. Nephrology, Dialysis, Transplantation, doi: 10.1093/ndt/gfq555(unspecified), 1-9. [More Information]
  • Morton, R., Howard, K., Webster, A., Snelling, P. (2010). Patient information about options for treatment: Methods of a national audit of information provision in chronic kidney disease. Nephrology, 15(6), 649-652. [More Information]
  • Ranguis, S., Li, D., Webster, A. (2010). Perioperative epidural steroids for lumbar spine surgery in degenerative spinal disease. A review. Journal of Neurosurgery: Spine, 13(6), 745-757. [More Information]
  • Cross, N., Macaskill, P., Hayen, A., Webster, A., O'Connell, P., Chapman, J., Nankivell, B., Craig, J. (2010). Prediction of Serum Creatinine In The First Month Following Uncomplicated Kidney Transplantation. Transplantation, 90(Suppl 2:876), 876.
  • Wong, G., Howard, K., Chapman, J., Chadban, S., Pollock, C., Phoon, R., Snelling, P., Tong, A., Salkeld, G., Webster, A., Craig, J. (2010). Quality of life of people with chronic kidney disease and cancer (QUICK) Study. Nephrology, 15(S4), 33-33. [More Information]
  • Wong, G., Howard, K., Webster, A., Chapman, J., Craig, J. (2010). Screening for renal cancer in recipients of kidney transplants. Nephrology, Dialysis, Transplantation, 26(5), 1729-1739. [More Information]
  • Wong, G., Howard, K., Webster, A., Chapman, J., Craig, J. (2010). Screening for Renal Cancer in Recipients of Kidney Transplants. Transplantation, 90(Suppl), 391-391.
  • Wang, L., Macaskill, P., Fahim, M., Craig, J., Mitchell, R., Hayen, A., Baines, L., Lord, S., Webster, A. (2010). Screening Tests for Coronary Artery Disease in Potential Kidney Transplant Recipients: A Systematic Review of Diagnostic Test Accuracy. Transplantation, 90(Suppl), 211-211.
  • Wong, G., Howard, K., Chapman, J., Chadban, S., Cross, N., Webster, A., Craig, J. (2010). Survival Benefits of Kidney Transplantation: Absolute Against Incremental Gains In Life Years. Transplantation, 90(Suppl:971), 971.
  • Brooks, R., Higgins, G., Webster, A. (2010). Systematic review of randomized controlled trial quality in pediatric kidney transplantation. Pediatric Nephrology, 25(12), 2383-2392. [More Information]
  • McGee, R., Nguyen, B., Mitchell, R., Craig, J., Webster, A. (2010). The number, coverage and quality of diagnostic test accuracy studies in nephrology. Nephrology, 15(S4), 78-78.
  • Tong, A., Howell, M., Wong, G., Webster, A., Howard, K., Craig, J. (2010). The perspectives of kidney transplant recipients on medicine taking: a systematic review of qualitative studies. Nephrology, Dialysis, Transplantation, 26(1), 1-11. [More Information]
  • Tong, A., Howell, M., Wong, G., Webster, A., Howard, K., Craig, J. (2010). The perspectives of kidney transplant recipients on medicine taking: a systematic review of qualitative studies. Nephrology, Dialysis, Transplantation, 15(S4), 64-64. [More Information]
  • Morton, R., Tong, A., Howard, K., Snelling, P., Webster, A. (2010). The views of patients and carers in treatment decision making for chronic kidney disease: a systematic review of qualitative studies. BMJ, 340(c112), c112-1-c112-10. [More Information]
  • Henderson, L., Masson, P., Flanc, R., Roberts, M., Craig, J., Webster, A. (2010). Treatment for diffuse proliferative lupus nephritis: an updated cochrane systematic review and meta-analysis. Nephrology, 15(S4), 50-50. [More Information]
  • Webster, A., Supramaniam, R., O’Connell, D., Chapman, J., Craig, J. (2010). Validity of registry data: Agreement between cancer records in an end-stage kidney disease registry (voluntary reporting) and a cancer register (statutory reporting). Nephrology, 15(4), 491-501. [More Information]
  • Morton, R., Moustakas, J., Howard, K., Webster, A., Snelling, P. (2009). A national audit of information provided to new chronic kidney disease stage 4 & 5 patients: results from a pilot study. Renal Society of Australasia Journal, 5(3), 138-146.
  • Cross, N., Webster, A., Masson, P., O'Connell, P., Craig, J. (2009). Antihypertensive treatment for kidney transplant recipients. Cochrane Database of Systematic Reviews, Article number CD003598(3), 1-157. [More Information]
  • Cross, N., Webster, A., Masson, P., O'Connell, P., Craig, J. (2009). Antihypertensives for kidney transplant recipients: systematic review and meta-analysis of randomized controlled trials. Transplantation, 88(1), 7-18. [More Information]
  • Perkovic, V., Venkataraman, V., Cooper, B., Zoungas, S., Webster, A. (2009). Antioxidants for chronic kidney disease (Protocol). Cochrane Database of Systematic Reviews, 2009 (4), 1-12. [More Information]
  • Wong, G., Hayen, A., Chapman, J., Webster, A., Wang, J., Mitchell, P., Craig, J. (2009). Association of CKD and Cancer Risk in Older People. Journal of the American Society of Nephrology, 20(6), 1341-1350. [More Information]
  • Vajdic, C., van Leeuwen, M., Webster, A., McCredie, M., Stewart, J., Chapman, J., Amin, J., McDonald, S., Grulich, A. (2009). Cutaneous Melanoma Is Related to Immune Suppression in Kidney Transplant Recipients. Cancer Epidemiology, Biomarkers and Prevention, 18(8), 2297-2303. [More Information]
  • Cross, N., Webster, A., O'Connell, P., Jeffreys, N., Dwyer, D., Craig, J. (2009). Diagnostic accuracy of blood qualitative nucleic acid testing for polyomavirus-associated nephropathy in kidney recipients. Nephrology, 14(3), 350-356. [More Information]
  • van Leeuwen, M., Grulich, A., Webster, A., McCredie, M., Stewart, J., McDonald, S., Amin, J., Kaldor, J., Chapman, J., Vajdic, C. (2009). Immunosuppression and other risk factors for early and late non-Hodgkin lymphoma after kidney transplantation. Blood, 114(3), 630-637. [More Information]
  • van Leeuwen, M., Grulich, A., McDonald, S., McCredie, M., Amin, J., Stewart, J., Webster, A., Chapman, J., Vajdic, C. (2009). Immunosuppression and other risk factors for lip cancer after kidney transplantation. Cancer Epidemiology, Biomarkers and Prevention, 18(2), 561-569. [More Information]
  • Masson, P., Matheson, S., Webster, A., Craig, J. (2009). Meta-analyses in prevention and treatment of urinary tract infections. Infectious Disease Clinics of North America, 23(2), 355-385. [More Information]
  • Conway, B., Webster, A., Ramsay, G., Morgan, N., Neary, J., Whitworth, C., Harty, J. (2009). Predicting mortality and uptake of renal replacement therapy in patients with stage 4 chronic kidney disease. Nephrology, Dialysis, Transplantation, 24(6), 1930-1937. [More Information]
  • Wong, G., Webster, A., Chapman, J., Craig, J. (2009). Reported cancer screening practices of nephrologists: results from a national survey. Nephrology, Dialysis, Transplantation, 24(7), 2136-2143. [More Information]
  • Craig, J., Webster, A., McDonald, S. (2009). The case of Azathioprine Versus Mycophenolate. Do Different Drugs Really Cause Different Transplant Outcomes? Transplantation, 87(6), 803-804. [More Information]
  • Morton, R., Howard, K., Webster, A., Wong, G., Craig, J. (2009). The cost-effectiveness of induction immunosuppression in kidney transplantation. Nephrology, Dialysis, Transplantation, 24(7), 2258-2269. [More Information]
  • Wong, G., Howard, K., Webster, A., Chapman, J., Craig, J. (2009). The health and economic impact of cervical cancer screening and human papillomavirus vaccination in kidney transplant recipients. Transplantation, 87(7), 1078-1091. [More Information]
  • Stewart, J., Vajdic, C., van Leeuwen, M., Amin, J., Webster, A., Chapman, J., McDonald, S., Grulich, A., McCredie, M. (2009). The pattern of excess cancer in dialysis and transplantation. Nephrology, Dialysis, Transplantation, 24(10), 3225-3231. [More Information]
  • Hodson, E., Craig, J., Webster, A., Strippoli, G. (2008). Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients (Review). Cochrane Database of Systematic Reviews, (2), 1-118. [More Information]
  • Craig, J., Webster, A., Mitchell, A., Irwig, L. (2008). Expanding the Evidence Base in Transplantation: More and Better Randomized Trials, and Extending the Value of Observational Data. Transplantation, 86(1), 32-35. [More Information]
  • Webster, A., Wong, G., Craig, J., Chapman, J. (2008). Managing Cancer Risk and Decision Making After Kidney Transplantation. American Journal Of Transplantation, 8(11), 2185-2191. [More Information]
  • Johnston, O., Rose, C., Webster, A., Gill, J. (2008). Sirolimus is Associated with New-Onset Diabetes in Kidney Transplant Recipients. Journal of the American Society of Nephrology, 19(7), 1411-1418. [More Information]
  • Webster, A., Craig, J., Simpson, J., Jones, M., Chapman, J. (2007). Identifying high risk groups and quantifying absolute risk of cancer after kidney transplantation: a cohort study of 15,183 recipients. American Journal Of Transplantation, 7(9), 2140-2151. [More Information]
  • Hodson, E., Jones, C., Strippoli, G., Webster, A., Craig, J. (2007). Immunoglobulins, vaccines or interferon for preventing cytomegalovirus disease in solid organ transplant recipients. Cochrane Database of Systematic Reviews, Cochrane Database of Systematic Reviews 2007(Issue 2. Art. No.: CD005129), 1-101. [More Information]
  • Vajdic, C., van Leeuwen, M., McDonald, S., McCredie, M., Law, M., Chapman, J., Webster, A., Kaldor, J., Grulich, A. (2007). Increased Incidence of Squamous Cell Carcinoma of Eye After Kidney Transplantation. Journal of the National Cancer Institute, 99(17), 1340-1342. [More Information]
  • Bath-Hextall, F., Leonardi-Bee, J., Somchand, N., Webster, A., Delitt, J., Perkins, W. (2007). Interventions for preventing non-melanoma skin cancers in high-risk groups. Cochrane Database of Systematic Reviews, DOI: 10.1002/14651858.CD005414.pub2(4), 5414 - 1-5414 - 58. [More Information]
  • Webster, A. (2007). The addition of anti-CD25 antibody induction to standard immunosuppressive therapy for kidney transplant recipients. Nephrology, 12(Suppl 1), S75-S84. [More Information]
  • Playford, E., Webster, A., Sorrell, T., Craig, J. (2006). Antifungal agents for preventing fungal infections in non-neutropenic critically ill and surgical patients: systematic review and meta-analysis of randomized clinical trials. Journal of Antimicrobial Chemotherapy. [More Information]
  • Playford, E., Webster, A., Sorrell, T., Craig, J. (2006). Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients. Cochrane Database of Systematic Reviews, 1(1), CD004920. [More Information]
  • Vajdic, C., McDonald, S., McCredie, M., van Leeuwen, M., Stewart, J., Law, M., Chapman, J., Webster, A., Kaldor, J., Grulich, A. (2006). Cancer incidence before and after kidney transplantation. JAMA: The Journal of the American Medical Association, 296(23), 2823-2831. [More Information]
  • Mitchell, R., Webster, A., Craig, J. (2006). Cochrane renal group report. American Journal of Kidney Diseases, 47(4), 686-691.
  • Webster, A., Ruster, L., Playford, E., Higgins, G., Chapman, J., Craig, J. (2006). IL2 receptor antagonists for renal transplant recipients: An updated meta-analysis of randomised trials. 84(3), A3-A3.
  • Webster, A., Pankhurst, T., Rinaldi, F., Chapman, J., Craig, J. (2006). Monoclonal and polyclonal antibody therapy for treating acute rejection in kidney transplant recipients: a systematic review of randomized trial data. Transplantation, 81(7), 953-965. [More Information]
  • Webster, A., Pankhurst, T., Rinaldi, F., Chapman, J., Craig, J. (2006). Polyclonal and monoclonal antibodies for treating acute rejection episodes in kidney transplant recipients (Review). Cochrane Database of Systematic Reviews, (Issue 2), 1-126. [More Information]
  • Geevasinga, N., Coleman, P., Webster, A., Roger, S. (2006). Proton pump inhibitors and acute interstitial nephritis. Clinical Gastroenterology and Hepatology, 4(5), 597-604. [More Information]
  • Webster, A., Craig, J., Chapman, J. (2006). Rate and relative risk of common cancers in kidney transplant recipients in Australia and New Zealand. Immunology and Cell Biology, 84(3), A13-A13.
  • Playford, E., Webster, A., Sorrell, T., Craig, J. (2006). Systematic review and meta-analysis of antifungal agents for preventing fungal infections in liver transplant recipients. European Journal of Clinical Microbiology and Infectious Diseases, 25(9), 549-561. [More Information]
  • Webster, A., Lee, V., Chapman, J., Craig, J. (2006). Target of rapamycin inhibitors (sirolimus and everolimus) for primary immunosuppression of kidney transplant recipients: a systematic review and meta-analysis of randomized trials. Transplantation, 81(9), 1234-1248. [More Information]
  • Hodson, E., Craig, J., Strippoli, G., Webster, A. (2005). Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients. Cochrane Database of Systematic Reviews, , 1-143. [More Information]
  • Hodson, E., Jones, C., Webster, A., Strippoli, G., Barclay, P., Kable, K., Vimalachandra, D., Craig, J. (2005). Antiviral medications to prevent cytomegalovirus disease and early death in recipients of solid-organ transplants: a systematic review of randomised controlled trials. The Lancet, 365(9477), 2105-2115. [More Information]
  • Hodson, E., Jones, C., Webster, A., Strippoli, G., Craig, J. (2005). Antiviral treatment after solid organ transplantation (Authors' reply). The Lancet, 366(9488), 807.
  • Mitchell, R., Webster, A., Craig, J. (2005). Cochrane Renal Group Report. American Journal of Kidney Diseases, 46(4), 774-779.
  • Mitchell, R., Webster, A., Hodson, E., Craig, J. (2005). Cochrane renal group report (July to December 2004 Trials). American Journal of Kidney Diseases, 45(4), 775-779.
  • Webster, A., Woodroffe, R., Taylor, R., Chapman, J., Craig, J. (2005). Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial data. BMJ: British Medical Journal, 331(7520), 1-11. [More Information]
  • Webster, A., Taylor, R., Chapman, J., Craig, J. (2005). Tacrolimus versus cyclosporin as primary immunosuppression for kidney transplant recipients (Review). Cochrane Database of Systematic Reviews, (4), 1-111. [More Information]
  • Pond, F., Serpell, J., Webster, A. (2005). Thyroid cancer in the renal transplant population: epidemiological study. ANZ Journal of Surgery. [More Information]
  • Playford, E., Webster, A., Craig, J., Sorrell, T. (2004). Antifungal Agents For Preventing Fungal Infections In Solid Organ Transplant Recipients. Cochrane Database of Systematic Reviews, 3, 1-92.
  • Mitchell, R., Webster, A., Craig, J. (2004). Cochrane Renal Group Report. American Journal of Kidney Diseases, 44(4), 768-772.
  • Webster, A., Playford, E., Higgins, G., Chapman, J., Craig, J. (2004). Interleukin 2 Receptor Antagonists For Kidney Transplant Recipients. Cochrane Database of Systematic Reviews, Jan 2004(1), CD003897.
  • Webster, A., Playford, E., Higgins, G., Chapman, J., Craig, J. (2004). Interleukin 2 Receptor Antagonists For Renal Transplant Recipients: A Meta-Analysis Of Randomized Trials. Transplantation, 77(2), 166-176.

Conferences

  • Chapman, J., D'Errico-Grigioni, A., Matesanz, R., Dominguez-Gil, B., Marazuela, R., Breindenbach, T., Fischer-Fröhlich, C., Kirste, G., Mahíllo, B., Moench, K., Webster, A. (2011). The Transmission of Malignancies. NOTIFY: Exploring Vigilance Notification for Organs, Tissues and Cells, Bologna, Italy: Editrice Compositori Srl.
  • Webster, A., Ruster, L., Playford, E., Higgins, G., Chapman, J., Craig, J. (2006). IL2 Receptor antagonists for renal transplant recipients: an updated meta-analysis of randomized trials. 24th Annual Scientific Meeting of the Transplantation Society of Australia and New Zealand.
  • Webster, A., O'Sullivan, C., Higgins, G., Craig, J. (2006). Outcome bias in the design of randomised trials of immunosuppression in kidney transplantation reported in medical journals. 24th Annual Scientific Meeting of the Transplantation Society of Australia and New Zealand (2006), Australia: Nature Publishing Group.
  • Webster, A., O'Sullivan, C., Higgins, G., Craig, J. (2006). Outcome bias in the design of randomized trials of immunosuppression in kidney transplantation reported in medical journals. 24th Annual Scientific Meeting of the Transplantation Society of Australia and New Zealand.
  • Webster, A., Craig, J., Chapman, J. (2006). Rate and relative risk of common cancer in kidney transplant recipients in Australia and New Zealand. 24th Annual Scientific Meeting of the Transplantation Society of Australia and New Zealand.
  • Webster, A., Lee, V., Powell, J., Chapman, J., Craig, J. (2004). (O78) Tor-Inhibitors (sirolimus and everolimus) for primary immunosuppression of renal transplant recipients: A meta-analysis randomized trials. IPNA meeting, 13th Congress.
  • Webster, A., Byrne, B., McDonald, S., Craig, J., Chapman, J. (2004). (O91) Incidence, risk and predictors of cancer after renal transplantation: An analysis of ANZDATA. IPNA meeting, 13th Congress.
  • Barclay, P., Kable, K., Webster, A., Chapman, J., Craig, J. (2004). (P413) Monoclonal and polyclonal antibody induction therapy for pancreas and kidney/pancreas transplantation: A meta-analysis of randomized trials. IPNA meeting, 13th Congress.
  • Playford, E., Webster, A., Craig, J., Sorrell, T. (2003). Antifungal prophylaxis in critically-ill ICU and surgical patients: A meta-analysis. 43rd ICAAC, American Society for Microbiology.
  • Playford, E., Webster, A., Craig, J., Sorrell, T. (2003). Antifungal prophylaxis in solid organ transplant recipients: A meta-analysis. 43rd ICAAC, American Society for Microbiology.
  • Webster, A., Playford, E., Higgins, G., Chapman, J., Craig, J. (2002). IL2 receptor antagonists for renal transplant recipients: a systematic review of randomised controlled trials. Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology.

2014

  • Lim, W., Turner, R., Chapman, J., Ma, M., Webster, A., Craig, J., Wong, G. (2014). Acute Rejection, T-Cell-Depleting Antibodies, and Cancer After Transplantation. Transplantation, 97(8), 817-925. [More Information]
  • Nagler, E., Webster, A., Bolignano, D., Haller, M., Nistor, I., van der Veer, S., Fouque, D., Van Biesen, W. (2014). European Renal Best Practice (ERBP) Guideline development methodology: towards the best possible guidelines. Nephrology, Dialysis, Transplantation, 29(4), 731-738. [More Information]
  • Buell, J., Shores, N., Gross, T., Chapman, J., Webster, A. (2014). Post-Transplant Lymphoproliferative Disorder. In James Neuberger, James Ferguson and Philip N. Newsome (Eds.), Liver Transplantation: Clinical Assessment and Management, (pp. 325-336). Oxford: John Wiley & Sons.
  • Neuen, B., Gunnarsson, R., Webster, A., Baer, R., Golledge, J., Mantha, M. (2014). Predictors of Patency after Balloon Angioplasty in Hemodialysis Fistulas: A Systematic Review. Journal of Vascular and Interventional Radiology, 25(6), 917-924. [More Information]
  • Iff, S., Wong, G., Webster, A., Flood, V., Wang, J., Mitchell, P., Craig, J. (2014). Relative Energy Balance, CKD, and Risk of Cardiovascular and All-Cause Mortality. American Journal of Kidney Diseases, 63(3), 437-445. [More Information]
  • Vajdic, C., Chong, A., Kelly, P., Meagher, N., van Leeuwen, M., Grulich, A., Webster, A. (2014). Survival After Cutaneous Melanoma in Kidney Transplant Recipients: A Population-Based Matched Cohort Study. American Journal of Transplantation, 14(6), 1368-1375. [More Information]
  • Myint, T., Rangan, G., Webster, A. (2014). Treatments to slow progression of autosomal dominant polycystic kidney disease: systematic review and meta -analysis of randomized trials. Nephrology, 19(4), 217-226. [More Information]

2013

  • Palmer, S., Di Micco, L., Razavian, M., Craig, J., Perkovic, V., Pellegrini, F., Jardine, M., Webster, A., Zoungas, S., Strippoli, G., et al (2013). Antiplatelet agents for chronic kidney disease. Cochrane Database of Systematic Reviews, 2013 (4), 1-136. [More Information]
  • Palmer, S., Di Micco, L., Razavian, M., Craig, J., Ravani, P., Perkovic, V., Tognoni, G., Graziano, G., Jardine, M., Pellegrini, F., Webster, A., Strippoli, G., et al (2013). Antiplatelet Therapy to Prevent Hemodialysis Vascular Access Failure: Systematic Review and Meta-analysis. American Journal of Kidney Diseases, 61(1), 112-122. [More Information]
  • Hodson, E., Ladhani, M., Webster, A., Strippoli, G., Craig, J. (2013). Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients. Cochrane Database of Systematic Reviews, 2, 1-198. [More Information]
  • Chapman, J., Webster, A., Wong, G. (2013). Cancer in the Transplant Recipient. Cold Spring Harbor Perspectives in Medicine, 3(7), 1-15. [More Information]
  • Tait, B., Susal, C., Gebel, H., Nickerson, P., Zachary, A., Claas, F., Reed, E., Bray, R., Campbell, P., Chapman, J., Webster, A., et al (2013). Consensus Guidelines on the Testing and Clinical Management Issues Associated With HLA and Non-HLA Antibodies in Transplantation. Transplantation, 95(1), 19-47. [More Information]
  • Masson, P., Duthie, F., Ruster, L., Kelly, P., Merrifield, A., Craig, J., Webster, A. (2013). Consistency and Completeness of Reported Outcomes in Randomized Trials of Primary Immunosuppression in Kidney Transplantation. American Journal of Transplantation, 13(11), 2892-2901. [More Information]
  • Kim, S., Webster, A., Craig, J. (2013). Current trends in immunosuppression following organ transplantation in children. Current Opinion in Organ Transplantation, 18(5), 537-542. [More Information]
  • Henderson, L., Masson, P., Craig, J., Roberts, M., Flanc, R., Strippoli, G., Webster, A. (2013). Induction and Maintenance Treatment of Proliferative Lupus Nephritis: A Meta-analysis of Randomized Controlled Trials. American Journal of Kidney Diseases, 61(1), 74-87. [More Information]
  • Tsoi, D., Porwal, M., Webster, A. (2013). Interventions for smoking cessation and reduction in individuals with schizophrenia. Cochrane Database of Systematic Reviews, 2, 1-101. [More Information]
  • Li, L., McGee, R., Isbister, G., Webster, A. (2013). Interventions for the symptoms and signs resulting from jellyfish stings (Review). Cochrane Database of Systematic Reviews, 2013 (12), 1-42. [More Information]
  • Owers, D., Webster, A., Strippoli, G., Kable, K., Hodson, E. (2013). Pre-emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant recipients (Review). Cochrane Database of Systematic Reviews, 2013 (2), 1-81. [More Information]
  • McGee, R., Craig, J., Rogerson, T., Webster, A. (2013). Systematic reviews of surgical procedures in children: Quantity, coverage and quality. Journal of Paediatrics and Child Health, 49(4), 319-324. [More Information]
  • Myint, T., Turner, R., Craig, J., Cross, N., Kable, K., Nankivell, B., Chapman, J., Webster, A., O'Connell, P., Dwyer, D., Jeoffreys, N., Wong, G., et al (2013). Test performance characteristics of quantitative nucleic acid testing for polyomaviruses in kidney and kidney-pancreas transplant recipients. Clinical Transplantation, 27(5), 571-579. [More Information]
  • Rogerson, T., Chen, S., Kok, J., Hayen, A., Craig, J., Sud, K., Kable, K., Webster, A. (2013). Tests for Latent Tuberculosis in People With ESRD: A Systematic Review. American Journal of Kidney Diseases, 61(1), 33-43. [More Information]
  • Wong, G., Turner, R., Chapman, J., Howell, M., Lim, W., Webster, A., Craig, J. (2013). Time on Dialysis and Cancer Risk After Kidney Transplantation. Transplantation, 95(1), 114-121. [More Information]

2012

  • Wyld, M., Morton, R., Hayen, A., Howard, K., Webster, A. (2012). A Systematic Review and Meta-Analysis of Utility-Based Quality of Life in Chronic Kidney Disease Treatments. PLoS Medicine, 9(9), 1-10. [More Information]
  • Nagler, E., Webster, A., Vanholder, R., Zoccali, C. (2012). Antidepressants for depression in stage 3-5 chronic kidney disease: a systematic review of pharmacokinetics, efficacy and safety with recommendations by European Renal Best Practice (ERBP). Nephrology, Dialysis, Transplantation, 27(10), 3736-3745. [More Information]
  • Jun, M., Venkataraman, V., Razavian, M., Cooper, B., Zoungas, S., Ninomiya, T., Webster, A., Perkovic, V. (2012). Antioxidants for chronic kidney disease (Review). Cochrane Database of Systematic Reviews, 10, 1-61. [More Information]
  • Webster, A., Wang, L. (2012). Cardiac testing for coronary artery disease in potential kidney transplant recipients. Nephrology, 17(5), 517-520. [More Information]
  • Wong, G., Howard, K., Chapman, J., Chadban, S., Cross, N., Tong, A., Webster, A., Craig, J. (2012). Comparative survival and economic benefits of deceased donor kidney transplantation and dialysis in people with varying ages and co-morbidities. PLoS One, 7(1), 1-9. [More Information]
  • Morton, R., Snelling, P., Webster, A., Rose, J., Masterson, R., Johnson, D., Howard, K. (2012). Dialysis Modality Preference of Patients With CKD and Family Caregivers: A Discrete-Choice Study. American Journal of Kidney Diseases, 60(1), 102-111. [More Information]
  • Palmer, S., Di Micco, L., Razavian, M., Craig, J., Perkovic, V., Pellegrini, F., Copetti, M., Graziano, G., Tognoni, G., Jardine, M., Webster, A., Strippoli, G., et al (2012). Effects of Antiplatelet Therapy on Mortality and Cardiovascular and Bleeding Outcomes in Persons With Chronic Kidney Disease: A Systematic Review and Meta-analysis. Annals of Internal Medicine, 156(6), 445-459. [More Information]
  • Morton, R., Snelling, P., Webster, A., Rose, J., Masterson, R., Johnson, D., Howard, K. (2012). Factors influencing patient choice of dialysis versus conservative care to treat end-stage kidney disease. CMAJ - Canadian Medical Association Journal, 184(5), E277-E283. [More Information]
  • Wong, G., Howard, K., Chapman, J., Pollock, C., Chadban, S., Salkeld, G., Tong, A., Williams, N., Webster, A., Craig, J. (2012). How do people with chronic kidney disease value cancer-related quality of life? Nephrology, 17(1), 32-41. [More Information]
  • Chadban, S., Barraclough, K., Campbell, S., Clark, C., Coates, P., Cohney, S., Cross, N., Eris, J., Henderson, L., Howell, M., O'Connell, P., Webster, A., Wong, G., et al (2012). KHA-CARI guideline: KHA-CARI Adaptation of the KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients. Nephrology, 17(3), 204-214. [More Information]
  • McGee, R., Webster, A., Rogerson, T., Craig, J. (2012). Medical device regulation in Australia: safe and effective? Medical Journal of Australia, 196(4), 256-260. [More Information]
  • Webster, A., Hodson, E. (2012). Parenteral versus oral iron therapy for adults and children with chronic kidney disease. Nephrology, 17(8), 774-775. [More Information]
  • Albaramki, J., Hodson, E., Craig, J., Webster, A. (2012). Parenteral versus oral iron therapy for adults and children with chronic kidney disease (Review). Cochrane Database of Systematic Reviews, 1, 1-97. [More Information]
  • Morton, R., Turner, R., Howard, K., Snelling, P., Webster, A. (2012). Patients Who Plan for Conservative Care Rather Than Dialysis: A National Observational Study in Australia. American Journal of Kidney Diseases, 59(3), 419-427. [More Information]
  • Webster, A., Peng, A., Kelly, P. (2012), The 35th Annual Report of the Australia and New Zealand Dialysis and Transplant Registry 2012 | Chapter 10 Cancer. , , , 10/1-10/9.
  • Webster, A., Mahady, S. (2012). The Importance of Quality Appraisal in Meta-analysis. Clinical Gastroenterology and Hepatology, 10(9), 1057-1057. [More Information]
  • Glotz, D., Chapman, J., Dharnidharka, V., Hanto, D., Castro, M., Hirschc, H., Leblond, V., Mehta, A., Moulin, B., Pagliuca, A., Webster, A., et al (2012). The Seville Expert Workshop for Progress in Posttransplant Lymphoproliferative Disorders. Transplantation, 94(8), 784-793. [More Information]
  • Henderson, L., Masson, P., Craig, J., Flanc, R., Roberts, M., Strippoli, G., Webster, A. (2012). Treatment for lupus nephritis (Review). Cochrane Database of Systematic Reviews, 12, 1-226. [More Information]

2011

  • Webster, A., Wong, G., McDonald, S. (2011). Cancer Report. In Stephen McDonald & Kylie Hurst (Eds.), ANZDATA Registry 2011 Report, (pp. 10-1-10-11). Australia: ANZDATA Registry Australia.
  • Wang, L., Fahim, M., Hayen, A., Mitchell, R., Baines, L., Lord, S., Craig, J., Webster, A. (2011). Cardiac testing for coronary artery disease in potential kidney transplant recipients. Cochrane Database of Systematic Reviews, 2011 (12), 1-104. [More Information]
  • Wang, L., Fahim, M., Hayen, A., Mitchell, R., Lord, S., Baines, L., Craig, J., Webster, A. (2011). Cardiac Testing for Coronary Artery Disease in Potential Kidney Transplant Recipients: A Systematic Review of Test Accuracy Studies. American Journal of Kidney Diseases, 57(3), 476-487. [More Information]
  • Morton, R., Tong, A., Webster, A., Snelling, P., Howard, K. (2011). Characteristics of dialysis important to patients and family caregivers: a mixed methods approach. Nephrology, Dialysis, Transplantation, 26(12), 4038-4046. [More Information]
  • McGee, R., Neuen, B., Mitchell, R., Craig, J., Webster, A. (2011). Diagnostic Test Studies in Nephrology: Quantity, Quality, and Scope. American Journal of Kidney Diseases, 58(6), 921-927. [More Information]
  • Komala, M., Pianta, T., Jardine, M., Webster, A., Perkovic, V. (2011). Interventions for preventing intradialytic hypotension inhaemodialysis patients (Protocol). Cochrane Database of Systematic Reviews, (12), 1-12. [More Information]
  • McGee, R., Bakens, A., Wiley, K., Riordan, S., Webster, A. (2011). Probiotics for patients with hepatic encephalopathy. Cochrane Database of Systematic Reviews, (11 article number CD008716), CD008716-1-CD008716-76. [More Information]
  • Wong, G., Howard, K., Webster, A., Chapman, J., Craig, J. (2011). Screening for renal cancer in recipients of kidney transplants. Nephrology, Dialysis, Transplantation, 26(5), 1729-1739. [More Information]
  • Wong, G., Howard, K., Chapman, J., Tong, A., Bourke, M., Hayen, A., Macaskill, P., Hope, R., Williams, N., Kieu, A., Allen, R., Chadban, S., Pollock, C., Webster, A., Craig, J., et al (2011). Test performance of faecal occult blood testing for the detection of bowel cancer in people with chronic kidney disease (DETECT) protocol. BMC Public Health, 11(June), 516-(7pp). [More Information]
  • Webster, A., Wong, G., Kelly, P. (2011), The 34th Annual Report of the Australia and New Zealand Dialysis and Transplant Registry 2011 | Chapter 10 Cancer. , , , 1-9.
  • Mahady, S., Webster, A., Walker, S., Sanyal, A., George, J. (2011). The role of thiazolidinediones in non-alcoholic steatohepatitis - A systematic review and meta analysis. Journal of Hepatology, 55(6), 1383-1390. [More Information]
  • Chapman, J., D'Errico-Grigioni, A., Matesanz, R., Dominguez-Gil, B., Marazuela, R., Breindenbach, T., Fischer-Fröhlich, C., Kirste, G., Mahíllo, B., Moench, K., Webster, A. (2011). The Transmission of Malignancies. NOTIFY: Exploring Vigilance Notification for Organs, Tissues and Cells, Bologna, Italy: Editrice Compositori Srl.
  • McGee, R., Su, M., Kelly, P., Higgins, G., Craig, J., Webster, A. (2011). Trial Registration and Declaration of Registration by Authors of Randomized Controlled Trials. Transplantation, 92(10), 1094-1100. [More Information]

2010

  • Razavian, M., Di Micco, L., Palmer, S., Craig, J., Perkovic, V., Zoungas, S., Webster, A., Jardine, M., Strippoli, G. (2010). Antiplatelet agents for chronic kidney disease. Cochrane Database of Systematic Reviews, 2010 (11), 1-16. [More Information]
  • Cross, N., Craig, J., Webster, A. (2010). Asking the right question and finding the right answers. Nephrology, 15(1), 8-11. [More Information]
  • Webster, A., Wong, G., McDonald, S. (2010). Cancer Report. In S. McDonald, L. Excell, B. Livingstone (Eds.), ANZDATA Registry Report 2010, (pp. 1-11). Australia: ANZDATA Registry Australia.
  • van Leeuwen, M., Webster, A., McCredie, M., Stewart, J., McDonald, S., Amin, J., Kaldor, J., Chapman, J., Vajdic, C., Grulich, A. (2010). Effect of reduced immunosuppression after kidney transplant failure on risk of cancer: population based retrospective cohort study. BMJ, 340(c570), c570-1-c570-6. [More Information]
  • Tsoi, D., Porwal, M., Webster, A. (2010). Efficacy and safety of bupropion for smoking cessation and reduction in schizophrenia: a systematic review and meta-analysis. British Journal of Psychiatry, 196(5), 346-353. [More Information]
  • Craig, J., Webster, A., Loy, C. (2010). How long should treatments be continued? BMJ, 341, 409-414. [More Information]
  • Kelly, P., Webster, A., Craig, J. (2010). How many patients do we need for a clinical trial? Demystifying sample size calculations. Nephrology, 15, 725-731. [More Information]
  • Cullis, J., Webster, A. (2010). How to get the most from the medical literature: Keeping up to date in nephrology. Nephrology, 15(3), 269-276. [More Information]
  • Webster, A., Cross, N., Mitchell, R., Craig, J. (2010). How to get the most from the medical literature; searching the medical literature effectively. Nephrology, 15(1), 12-19. [More Information]
  • Jun, M., Zoungas, S., Perkovic, V., Webster, A. (2010). How to read a report of a randomized controlled trial. Nephrology, 15(2), 153-157. [More Information]
  • Henderson, L., Craig, J., Willis, N., Tovey, D., Webster, A. (2010). How to write a Cochrane systematic review. Nephrology, 15(6), 617-624. [More Information]
  • Webster, A., Ruster, L., McGee, R., Matheson, S., Higgins, G., Willis, N., Chapman, J., Craig, J. (2010). Interleukin 2 receptor antagonists for kidney transplant recipients. Cochrane Database of Systematic Reviews, CD003897(1), 1-146. [More Information]
  • Webster, A., Ruster, L., McGee, R., Matheson, S., Higgins, G., Willis, N., Chapman, J., Craig, J. (2010). Interleukin-2 Receptor Antagonists Versus ATG FOR Kidney Transplant Recipients; An Updated Cochrane Systematic Review. Transplantation, 90(Suppl: 22), 22.
  • Tsoi, D., Porwal, M., Webster, A. (2010). Interventions for smoking cessation and reduction in individuals with schizophrenia (Review). Cochrane Database of Systematic Reviews, 6(6), 1-75. [More Information]
  • McGee, R., Su, M., Kelly, P., Higgins, G., Craig, J., Webster, A. (2010). Is trial registration working in nephrology? Nephrology, 15(S4), 78-78. [More Information]
  • Wong, G., Howard, K., Chapman, J., Cross, N., Chadban, S., Webster, A., Craig, J. (2010). Life years gain and cost-savings on the kidney transplant waiting list. Transplantation, 90(Suppl 972), 972.
  • Gallagher, M., Kelly, P., Jardine, M., Perkovic, V., Cass, A., Craig, J., Eris, J., Webster, A. (2010). Long-Term Cancer Risk of Immunosuppressive Regimens after Kidney Transplantation. Journal of the American Society of Nephrology, 21(5), 852-858. [More Information]
  • Vajdic, C., van Leeuwen, M., Turner, J., McDonald, A., Webster, A., McDonald, S., Chapman, J., Kaldor, J., Grulich, A. (2010). No excess risk of follicular lymphoma in kidney transplant and HIV-related immune deficiency. International Journal of Cancer, 127, 2732-2735. [More Information]
  • Cross, N., Macaskill, P., Hayen, A., Webster, A., Wong, G., O'Connell, P., Chapman, J., Nankivell, B., Craig, J. (2010). Optimizing Serum Creatinine Monitoring For The Rapid Detection Of Complications In The Early Post-Kidney Transplant Period. Transplantation, 90(Suppl 2:977), 977.
  • Morton, R., Howard, K., Webster, A., Snelling, P. (2010). Patient INformation about Options for Treatment (PINOT): a prospective national study of information given to incident CKD Stage 5 patients. Nephrology, Dialysis, Transplantation, doi: 10.1093/ndt/gfq555(unspecified), 1-9. [More Information]
  • Morton, R., Howard, K., Webster, A., Snelling, P. (2010). Patient information about options for treatment: Methods of a national audit of information provision in chronic kidney disease. Nephrology, 15(6), 649-652. [More Information]
  • Ranguis, S., Li, D., Webster, A. (2010). Perioperative epidural steroids for lumbar spine surgery in degenerative spinal disease. A review. Journal of Neurosurgery: Spine, 13(6), 745-757. [More Information]
  • Cross, N., Macaskill, P., Hayen, A., Webster, A., O'Connell, P., Chapman, J., Nankivell, B., Craig, J. (2010). Prediction of Serum Creatinine In The First Month Following Uncomplicated Kidney Transplantation. Transplantation, 90(Suppl 2:876), 876.
  • Matheson, S., Masson, P., Webster, A., Craig, J. (2010). Prophylaxis and Treatment of Urinary Tract Infections in Adults. In Philipp Dahm and Roger Dmochowski (Eds.), Evidence-Based Urology, (pp. 72-93). United Kingdom: Wiley-Blackwell Publishing.
  • Wong, G., Howard, K., Chapman, J., Chadban, S., Pollock, C., Phoon, R., Snelling, P., Tong, A., Salkeld, G., Webster, A., Craig, J. (2010). Quality of life of people with chronic kidney disease and cancer (QUICK) Study. Nephrology, 15(S4), 33-33. [More Information]
  • Wong, G., Howard, K., Webster, A., Chapman, J., Craig, J. (2010). Screening for renal cancer in recipients of kidney transplants. Nephrology, Dialysis, Transplantation, 26(5), 1729-1739. [More Information]
  • Wong, G., Howard, K., Webster, A., Chapman, J., Craig, J. (2010). Screening for Renal Cancer in Recipients of Kidney Transplants. Transplantation, 90(Suppl), 391-391.
  • Wang, L., Macaskill, P., Fahim, M., Craig, J., Mitchell, R., Hayen, A., Baines, L., Lord, S., Webster, A. (2010). Screening Tests for Coronary Artery Disease in Potential Kidney Transplant Recipients: A Systematic Review of Diagnostic Test Accuracy. Transplantation, 90(Suppl), 211-211.
  • Wong, G., Howard, K., Chapman, J., Chadban, S., Cross, N., Webster, A., Craig, J. (2010). Survival Benefits of Kidney Transplantation: Absolute Against Incremental Gains In Life Years. Transplantation, 90(Suppl:971), 971.
  • Brooks, R., Higgins, G., Webster, A. (2010). Systematic review of randomized controlled trial quality in pediatric kidney transplantation. Pediatric Nephrology, 25(12), 2383-2392. [More Information]
  • Webster, A., Wong, G., McDonald, S. (2010), The 33rd Annual Report of the Australia and New Zealand Dialysis and Transplant Registry 2010 | Chapter 10 Cancer. , , , 10/1-10/11.
  • McGee, R., Nguyen, B., Mitchell, R., Craig, J., Webster, A. (2010). The number, coverage and quality of diagnostic test accuracy studies in nephrology. Nephrology, 15(S4), 78-78.
  • Tong, A., Howell, M., Wong, G., Webster, A., Howard, K., Craig, J. (2010). The perspectives of kidney transplant recipients on medicine taking: a systematic review of qualitative studies. Nephrology, Dialysis, Transplantation, 26(1), 1-11. [More Information]
  • Tong, A., Howell, M., Wong, G., Webster, A., Howard, K., Craig, J. (2010). The perspectives of kidney transplant recipients on medicine taking: a systematic review of qualitative studies. Nephrology, Dialysis, Transplantation, 15(S4), 64-64. [More Information]
  • Morton, R., Tong, A., Howard, K., Snelling, P., Webster, A. (2010). The views of patients and carers in treatment decision making for chronic kidney disease: a systematic review of qualitative studies. BMJ, 340(c112), c112-1-c112-10. [More Information]
  • Henderson, L., Masson, P., Flanc, R., Roberts, M., Craig, J., Webster, A. (2010). Treatment for diffuse proliferative lupus nephritis: an updated cochrane systematic review and meta-analysis. Nephrology, 15(S4), 50-50. [More Information]
  • Webster, A., Supramaniam, R., O’Connell, D., Chapman, J., Craig, J. (2010). Validity of registry data: Agreement between cancer records in an end-stage kidney disease registry (voluntary reporting) and a cancer register (statutory reporting). Nephrology, 15(4), 491-501. [More Information]

2009

  • Morton, R., Moustakas, J., Howard, K., Webster, A., Snelling, P. (2009). A national audit of information provided to new chronic kidney disease stage 4 & 5 patients: results from a pilot study. Renal Society of Australasia Journal, 5(3), 138-146.
  • Cross, N., Webster, A., Masson, P., O'Connell, P., Craig, J. (2009). Antihypertensive treatment for kidney transplant recipients. Cochrane Database of Systematic Reviews, Article number CD003598(3), 1-157. [More Information]
  • Cross, N., Webster, A., Masson, P., O'Connell, P., Craig, J. (2009). Antihypertensives for kidney transplant recipients: systematic review and meta-analysis of randomized controlled trials. Transplantation, 88(1), 7-18. [More Information]
  • Perkovic, V., Venkataraman, V., Cooper, B., Zoungas, S., Webster, A. (2009). Antioxidants for chronic kidney disease (Protocol). Cochrane Database of Systematic Reviews, 2009 (4), 1-12. [More Information]
  • Wong, G., Hayen, A., Chapman, J., Webster, A., Wang, J., Mitchell, P., Craig, J. (2009). Association of CKD and Cancer Risk in Older People. Journal of the American Society of Nephrology, 20(6), 1341-1350. [More Information]
  • Vajdic, C., van Leeuwen, M., Webster, A., McCredie, M., Stewart, J., Chapman, J., Amin, J., McDonald, S., Grulich, A. (2009). Cutaneous Melanoma Is Related to Immune Suppression in Kidney Transplant Recipients. Cancer Epidemiology, Biomarkers and Prevention, 18(8), 2297-2303. [More Information]
  • Cross, N., Webster, A., O'Connell, P., Jeffreys, N., Dwyer, D., Craig, J. (2009). Diagnostic accuracy of blood qualitative nucleic acid testing for polyomavirus-associated nephropathy in kidney recipients. Nephrology, 14(3), 350-356. [More Information]
  • van Leeuwen, M., Grulich, A., Webster, A., McCredie, M., Stewart, J., McDonald, S., Amin, J., Kaldor, J., Chapman, J., Vajdic, C. (2009). Immunosuppression and other risk factors for early and late non-Hodgkin lymphoma after kidney transplantation. Blood, 114(3), 630-637. [More Information]
  • van Leeuwen, M., Grulich, A., McDonald, S., McCredie, M., Amin, J., Stewart, J., Webster, A., Chapman, J., Vajdic, C. (2009). Immunosuppression and other risk factors for lip cancer after kidney transplantation. Cancer Epidemiology, Biomarkers and Prevention, 18(2), 561-569. [More Information]
  • Masson, P., Matheson, S., Webster, A., Craig, J. (2009). Meta-analyses in prevention and treatment of urinary tract infections. Infectious Disease Clinics of North America, 23(2), 355-385. [More Information]
  • Conway, B., Webster, A., Ramsay, G., Morgan, N., Neary, J., Whitworth, C., Harty, J. (2009). Predicting mortality and uptake of renal replacement therapy in patients with stage 4 chronic kidney disease. Nephrology, Dialysis, Transplantation, 24(6), 1930-1937. [More Information]
  • Wong, G., Webster, A., Chapman, J., Craig, J. (2009). Reported cancer screening practices of nephrologists: results from a national survey. Nephrology, Dialysis, Transplantation, 24(7), 2136-2143. [More Information]
  • Webster, A., Wong, G., McDonald, S. (2009), The 32nd Annual Report of the Australia and New Zealand Dialysis and Transplant Registry 2009 | Chapter 10 Cancer. , , , 10/1-10/8.
  • Craig, J., Webster, A., McDonald, S. (2009). The case of Azathioprine Versus Mycophenolate. Do Different Drugs Really Cause Different Transplant Outcomes? Transplantation, 87(6), 803-804. [More Information]
  • Morton, R., Howard, K., Webster, A., Wong, G., Craig, J. (2009). The cost-effectiveness of induction immunosuppression in kidney transplantation. Nephrology, Dialysis, Transplantation, 24(7), 2258-2269. [More Information]
  • Wong, G., Howard, K., Webster, A., Chapman, J., Craig, J. (2009). The health and economic impact of cervical cancer screening and human papillomavirus vaccination in kidney transplant recipients. Transplantation, 87(7), 1078-1091. [More Information]
  • Stewart, J., Vajdic, C., van Leeuwen, M., Amin, J., Webster, A., Chapman, J., McDonald, S., Grulich, A., McCredie, M. (2009). The pattern of excess cancer in dialysis and transplantation. Nephrology, Dialysis, Transplantation, 24(10), 3225-3231. [More Information]

2008

  • Hodson, E., Craig, J., Webster, A., Strippoli, G. (2008). Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients (Review). Cochrane Database of Systematic Reviews, (2), 1-118. [More Information]
  • Craig, J., Webster, A., Mitchell, A., Irwig, L. (2008). Expanding the Evidence Base in Transplantation: More and Better Randomized Trials, and Extending the Value of Observational Data. Transplantation, 86(1), 32-35. [More Information]
  • Webster, A., Wong, G., Craig, J., Chapman, J. (2008). Managing Cancer Risk and Decision Making After Kidney Transplantation. American Journal Of Transplantation, 8(11), 2185-2191. [More Information]
  • Murali, K., Webster, A. (2008). Post Transplant Malignancy. In David Harris (Eds.), Clinical Cases in Kidney Disease, (pp. 355-372). Australia: McGraw Hill.
  • Johnston, O., Rose, C., Webster, A., Gill, J. (2008). Sirolimus is Associated with New-Onset Diabetes in Kidney Transplant Recipients. Journal of the American Society of Nephrology, 19(7), 1411-1418. [More Information]
  • Webster, A., Wong, G. (2008), The Thirty First Report: Australia and New Zealand Dialysis and Transplant Registry 2008 | Chapter 10 Cancer Report. , , , 10-1-10-5.

2007

  • Webster, A., Craig, J., Simpson, J., Jones, M., Chapman, J. (2007). Identifying high risk groups and quantifying absolute risk of cancer after kidney transplantation: a cohort study of 15,183 recipients. American Journal Of Transplantation, 7(9), 2140-2151. [More Information]
  • Hodson, E., Jones, C., Strippoli, G., Webster, A., Craig, J. (2007). Immunoglobulins, vaccines or interferon for preventing cytomegalovirus disease in solid organ transplant recipients. Cochrane Database of Systematic Reviews, Cochrane Database of Systematic Reviews 2007(Issue 2. Art. No.: CD005129), 1-101. [More Information]
  • Vajdic, C., van Leeuwen, M., McDonald, S., McCredie, M., Law, M., Chapman, J., Webster, A., Kaldor, J., Grulich, A. (2007). Increased Incidence of Squamous Cell Carcinoma of Eye After Kidney Transplantation. Journal of the National Cancer Institute, 99(17), 1340-1342. [More Information]
  • Bath-Hextall, F., Leonardi-Bee, J., Somchand, N., Webster, A., Delitt, J., Perkins, W. (2007). Interventions for preventing non-melanoma skin cancers in high-risk groups. Cochrane Database of Systematic Reviews, DOI: 10.1002/14651858.CD005414.pub2(4), 5414 - 1-5414 - 58. [More Information]
  • Murali, K., Webster, A. (2007). Post-transplant malignancy. In David Harris (Eds.), Clinical Cases in Kidney Disease, (pp. 426-444). Australia: McGraw Hill.
  • Webster, A. (2007). The addition of anti-CD25 antibody induction to standard immunosuppressive therapy for kidney transplant recipients. Nephrology, 12(Suppl 1), S75-S84. [More Information]

2006

  • Playford, E., Webster, A., Sorrell, T., Craig, J. (2006). Antifungal agents for preventing fungal infections in non-neutropenic critically ill and surgical patients: systematic review and meta-analysis of randomized clinical trials. Journal of Antimicrobial Chemotherapy. [More Information]
  • Playford, E., Webster, A., Sorrell, T., Craig, J. (2006). Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients. Cochrane Database of Systematic Reviews, 1(1), CD004920. [More Information]
  • Vajdic, C., McDonald, S., McCredie, M., van Leeuwen, M., Stewart, J., Law, M., Chapman, J., Webster, A., Kaldor, J., Grulich, A. (2006). Cancer incidence before and after kidney transplantation. JAMA: The Journal of the American Medical Association, 296(23), 2823-2831. [More Information]
  • Mitchell, R., Webster, A., Craig, J. (2006). Cochrane renal group report. American Journal of Kidney Diseases, 47(4), 686-691.
  • Webster, A., Ruster, L., Playford, E., Higgins, G., Chapman, J., Craig, J. (2006). IL2 receptor antagonists for renal transplant recipients: An updated meta-analysis of randomised trials. 84(3), A3-A3.
  • Webster, A., Ruster, L., Playford, E., Higgins, G., Chapman, J., Craig, J. (2006). IL2 Receptor antagonists for renal transplant recipients: an updated meta-analysis of randomized trials. 24th Annual Scientific Meeting of the Transplantation Society of Australia and New Zealand.
  • Webster, A., Pankhurst, T., Rinaldi, F., Chapman, J., Craig, J. (2006). Monoclonal and polyclonal antibody therapy for treating acute rejection in kidney transplant recipients: a systematic review of randomized trial data. Transplantation, 81(7), 953-965. [More Information]
  • Webster, A., O'Sullivan, C., Higgins, G., Craig, J. (2006). Outcome bias in the design of randomised trials of immunosuppression in kidney transplantation reported in medical journals. 24th Annual Scientific Meeting of the Transplantation Society of Australia and New Zealand (2006), Australia: Nature Publishing Group.
  • Webster, A., O'Sullivan, C., Higgins, G., Craig, J. (2006). Outcome bias in the design of randomized trials of immunosuppression in kidney transplantation reported in medical journals. 24th Annual Scientific Meeting of the Transplantation Society of Australia and New Zealand.
  • Webster, A., Pankhurst, T., Rinaldi, F., Chapman, J., Craig, J. (2006). Polyclonal and monoclonal antibodies for treating acute rejection episodes in kidney transplant recipients (Review). Cochrane Database of Systematic Reviews, (Issue 2), 1-126. [More Information]
  • Geevasinga, N., Coleman, P., Webster, A., Roger, S. (2006). Proton pump inhibitors and acute interstitial nephritis. Clinical Gastroenterology and Hepatology, 4(5), 597-604. [More Information]
  • Webster, A., Craig, J., Chapman, J. (2006). Rate and relative risk of common cancer in kidney transplant recipients in Australia and New Zealand. 24th Annual Scientific Meeting of the Transplantation Society of Australia and New Zealand.
  • Webster, A., Craig, J., Chapman, J. (2006). Rate and relative risk of common cancers in kidney transplant recipients in Australia and New Zealand. Immunology and Cell Biology, 84(3), A13-A13.
  • Playford, E., Webster, A., Sorrell, T., Craig, J. (2006). Systematic review and meta-analysis of antifungal agents for preventing fungal infections in liver transplant recipients. European Journal of Clinical Microbiology and Infectious Diseases, 25(9), 549-561. [More Information]
  • Webster, A., Lee, V., Chapman, J., Craig, J. (2006). Target of rapamycin inhibitors (sirolimus and everolimus) for primary immunosuppression of kidney transplant recipients: a systematic review and meta-analysis of randomized trials. Transplantation, 81(9), 1234-1248. [More Information]

2005

  • Hodson, E., Craig, J., Strippoli, G., Webster, A. (2005). Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients. Cochrane Database of Systematic Reviews, , 1-143. [More Information]
  • Hodson, E., Jones, C., Webster, A., Strippoli, G., Barclay, P., Kable, K., Vimalachandra, D., Craig, J. (2005). Antiviral medications to prevent cytomegalovirus disease and early death in recipients of solid-organ transplants: a systematic review of randomised controlled trials. The Lancet, 365(9477), 2105-2115. [More Information]
  • Hodson, E., Jones, C., Webster, A., Strippoli, G., Craig, J. (2005). Antiviral treatment after solid organ transplantation (Authors' reply). The Lancet, 366(9488), 807.
  • Mitchell, R., Webster, A., Craig, J. (2005). Cochrane Renal Group Report. American Journal of Kidney Diseases, 46(4), 774-779.
  • Mitchell, R., Webster, A., Hodson, E., Craig, J. (2005). Cochrane renal group report (July to December 2004 Trials). American Journal of Kidney Diseases, 45(4), 775-779.
  • Webster, A., Woodroffe, R., Taylor, R., Chapman, J., Craig, J. (2005). Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial data. BMJ: British Medical Journal, 331(7520), 1-11. [More Information]
  • Webster, A., Taylor, R., Chapman, J., Craig, J. (2005). Tacrolimus versus cyclosporin as primary immunosuppression for kidney transplant recipients (Review). Cochrane Database of Systematic Reviews, (4), 1-111. [More Information]
  • Pond, F., Serpell, J., Webster, A. (2005). Thyroid cancer in the renal transplant population: epidemiological study. ANZ Journal of Surgery. [More Information]

2004

  • Webster, A., Lee, V., Powell, J., Chapman, J., Craig, J. (2004). (O78) Tor-Inhibitors (sirolimus and everolimus) for primary immunosuppression of renal transplant recipients: A meta-analysis randomized trials. IPNA meeting, 13th Congress.
  • Webster, A., Byrne, B., McDonald, S., Craig, J., Chapman, J. (2004). (O91) Incidence, risk and predictors of cancer after renal transplantation: An analysis of ANZDATA. IPNA meeting, 13th Congress.
  • Barclay, P., Kable, K., Webster, A., Chapman, J., Craig, J. (2004). (P413) Monoclonal and polyclonal antibody induction therapy for pancreas and kidney/pancreas transplantation: A meta-analysis of randomized trials. IPNA meeting, 13th Congress.
  • Playford, E., Webster, A., Craig, J., Sorrell, T. (2004). Antifungal Agents For Preventing Fungal Infections In Solid Organ Transplant Recipients. Cochrane Database of Systematic Reviews, 3, 1-92.
  • Mitchell, R., Webster, A., Craig, J. (2004). Cochrane Renal Group Report. American Journal of Kidney Diseases, 44(4), 768-772.
  • Webster, A., Playford, E., Higgins, G., Chapman, J., Craig, J. (2004). Interleukin 2 Receptor Antagonists For Kidney Transplant Recipients. Cochrane Database of Systematic Reviews, Jan 2004(1), CD003897.
  • Webster, A., Playford, E., Higgins, G., Chapman, J., Craig, J. (2004). Interleukin 2 Receptor Antagonists For Renal Transplant Recipients: A Meta-Analysis Of Randomized Trials. Transplantation, 77(2), 166-176.

2003

  • Playford, E., Webster, A., Craig, J., Sorrell, T. (2003). Antifungal prophylaxis in critically-ill ICU and surgical patients: A meta-analysis. 43rd ICAAC, American Society for Microbiology.
  • Playford, E., Webster, A., Craig, J., Sorrell, T. (2003). Antifungal prophylaxis in solid organ transplant recipients: A meta-analysis. 43rd ICAAC, American Society for Microbiology.

2002

  • Webster, A., Playford, E., Higgins, G., Chapman, J., Craig, J. (2002). IL2 receptor antagonists for renal transplant recipients: a systematic review of randomised controlled trials. Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology.

To update your profile click here. For support on your academic profile contact .